|
|
Volumn 178, Issue 5 SUPPL., 1998, Pages 1502-1506
|
|
Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HlV)-uninfected recipients of candidate HIV vaccines
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGEN P24;
GLYCOPROTEIN GP 120;
GLYCOPROTEIN GP 160;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOLOGICAL ADJUVANT;
N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;
NEUTRALIZING ANTIBODY;
PHYTOHEMAGGLUTININ;
PLACEBO;
RECOMBINANT VACCINE;
TRITON X 100;
ADULT;
ANTIBODY PRODUCTION;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALE;
PRIORITY JOURNAL;
RECIPIENT;
SYNCYTIUM;
T LYMPHOCYTE;
VACCINATION;
VIRUS ISOLATION;
VIRUS NEUTRALIZATION;
VIRUS STRAIN;
ADOLESCENT;
ADULT;
AIDS VACCINES;
ANTIGENIC VARIATION;
FEMALE;
GIANT CELLS;
HIV ANTIBODIES;
HIV ENVELOPE PROTEIN GP160;
HIV-1;
HUMANS;
MALE;
MIDDLE AGED;
|
|
EID: 0031751653
PISSN: 00221899
EISSN: None
Source Type: Journal
DOI: 10.1086/314452 Document Type: Article |
|
Times cited : (17)
|
|
References (2)
|
